Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-06, Vol.189 (5), p.985-992
Hauptverfasser:	Dupré, Anastasia, Michot, Jean‐Marie, Schoeffler, Amélie, Frumholtz, Laure, Baroudjian, Barouyr, Delyon, Julie, Lebbe, Céleste, Lambotte, Olivier
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy Fatal Outcome Female France - epidemiology haematotoxicity haemophagocytic lymphohistiocytosis Hematology Humans Immune checkpoint Immune Checkpoint Inhibitors - adverse effects Immune Checkpoint Inhibitors - therapeutic use Immunotherapy - adverse effects Ipilimumab - adverse effects Ipilimumab - therapeutic use Life Sciences & Biomedicine Literature reviews Lymphohistiocytosis, Hemophagocytic - chemically induced Lymphohistiocytosis, Hemophagocytic - epidemiology Male Middle Aged Neoplasms - drug therapy Nivolumab - adverse effects Nivolumab - therapeutic use Science & Technology tumour immunotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!